
    
      The objectives of this study are:

        -  To assess the safety and tolerability of treatment with VLI.

        -  To determine the maximum tolerated dose (MTD) of VLI.

        -  To characterize the pharmacokinetic (PK) profile of VLI.

        -  To explore preliminary tumor response of VLI.
    
  